
    
      Prospective, single center, randomized, double-masked, placebo controlled study. Subjects
      will be randomized to one of the following treatment arms to dose four times per day (QID)
      for 8 days between Visits 4 and 5.

        -  Prednisolone phosphate

        -  Tears Naturale II Ophthalmic Solution (Placebo)

      Duration:

      Approximately 19 days

      Controls:

      Artificial Tears (Tears NaturaleÂ® II)
    
  